Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernanda Laezza

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
British Journal of Pharmacology|April 28, 2026
Targeting the noncatalytic activity of GSK3β modulates neuronal excitability in medium spiny neurons via Nav1.6 interactionsAditya K Singh, Zahra Haghighijoo, Akanksha Gurtu, et al.
Cell Reports|April 12, 2018
Environmental Enrichment and Social Isolation Mediate Neuroplasticity of Medium Spiny Neurons through the GSK3 PathwayFederico Scala, Miroslav N Nenov, Elizabeth J Crofton, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 28, 2025
Inhibition of the GSK3β/Nav1.6 complex suppresses early-stage Alzheimer's hyperexcitabilityTimothy John Baumgartner, Manuel Silva-Pérez, Zahra Haghighijoo, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
The Regional Vulnerability Index (RVI) as a Neuroimaging-Based Biomarker for Autism: Associations with Likelihood, Cognition, and Longitudinal Social OutcomesAntonio Pagán, Katherine E Lawrence, Jan Buitelaar, et al.
Molecular Psychiatry|February 7, 2025
βIV spectrin abundancy, cellular distribution and sensitivity to AKT/GSK3 regulation in schizophreniaJessica Di Re, Michela Marini, Syed Ibrar Hussain, et al.
Journal of Neuroinflammation|December 20, 2023
TNFR1 signaling converging on FGF14 controls neuronal hyperactivity and sickness behavior in experimental cerebral malariaNolan M Dvorak, Nadia D Domingo, Cynthia M Tapia, et al.
Nature Communications|January 2, 2025
Enhanced motivated behavior mediated by pharmacological targeting of the FGF14/Na<sub>v</sub>1.6 complex in nucleus accumbens neuronsNolan M Dvorak, Paul A Wadsworth, Guillermo Aquino-Miranda, et al.
The Journal of Clinical Investigation|July 15, 2025
Sensory neuron-expressed FGF13 controls nociceptive signaling in diabetic neuropathy modelsAditya K Singh, Matteo Bernabucci, Nolan M Dvorak, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
British Journal of Pharmacology|April 28, 2026
Targeting the noncatalytic activity of GSK3β modulates neuronal excitability in medium spiny neurons via Nav1.6 interactionsAditya K Singh, Zahra Haghighijoo, Akanksha Gurtu, et al.
Cell Reports|April 12, 2018
Environmental Enrichment and Social Isolation Mediate Neuroplasticity of Medium Spiny Neurons through the GSK3 PathwayFederico Scala, Miroslav N Nenov, Elizabeth J Crofton, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 28, 2025
Inhibition of the GSK3β/Nav1.6 complex suppresses early-stage Alzheimer's hyperexcitabilityTimothy John Baumgartner, Manuel Silva-Pérez, Zahra Haghighijoo, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
The Regional Vulnerability Index (RVI) as a Neuroimaging-Based Biomarker for Autism: Associations with Likelihood, Cognition, and Longitudinal Social OutcomesAntonio Pagán, Katherine E Lawrence, Jan Buitelaar, et al.
Molecular Psychiatry|February 7, 2025
βIV spectrin abundancy, cellular distribution and sensitivity to AKT/GSK3 regulation in schizophreniaJessica Di Re, Michela Marini, Syed Ibrar Hussain, et al.
Journal of Neuroinflammation|December 20, 2023
TNFR1 signaling converging on FGF14 controls neuronal hyperactivity and sickness behavior in experimental cerebral malariaNolan M Dvorak, Nadia D Domingo, Cynthia M Tapia, et al.
Nature Communications|January 2, 2025
Enhanced motivated behavior mediated by pharmacological targeting of the FGF14/Na<sub>v</sub>1.6 complex in nucleus accumbens neuronsNolan M Dvorak, Paul A Wadsworth, Guillermo Aquino-Miranda, et al.
The Journal of Clinical Investigation|July 15, 2025
Sensory neuron-expressed FGF13 controls nociceptive signaling in diabetic neuropathy modelsAditya K Singh, Matteo Bernabucci, Nolan M Dvorak, et al.
Pageof 9